Human Gene Set: GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN


Standard name GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN
Systematic name M8129
Brief description Genes down-regulated in AGS cells (gastric adenocarcinoma): control versus H. pylori LPS.
Full description or abstract This study set out to identify global changes in gene expression in AGS gastric epithelial cells following 8 hours stimulation with 10 ?g/ml lipopolysaccharide (LPS) from the gastric pathogen H. pylori. Microarray analysis was used to compare changes in gene expression between cells treated with 10 ?g/ml H. pylori LPS and untreated cells at the same time point.
Collection C7: Immunologic Signature
      IMMUNESIGDB: ImmuneSigDB
Source publication Pubmed 21220698   Authors: Smith SM,Moran AP,Duggan SP,Ahmed SE,Mohamed AS,Windle HJ,O'Neill LA,Kelleher DP
Exact source GSE25146_3045_200_DN
Related gene sets (show 3 additional gene sets from the source publication)
External links
Filtered by similarity ?
Source species Homo sapiens
Contributed by Jernej Godec (Dana-Farber Cancer Institute)
Source platform or
identifier namespace		 HUMAN_GENE_SYMBOL
Dataset references (show 1 datasets)
Download gene set format: grp | gmt | xml | json | TSV metadata
Compute overlaps ? (show collections to investigate for overlap with this gene set)
Compendia expression profiles ? NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)

Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Advanced query Further investigate these 166 genes
Gene families ? Categorize these 166 genes by gene family
Show members (show 200 source identifiers mapped to 166 genes)
Version history 7.3: Moved to ImmuneSigDB sub-collection.

See MSigDB license terms here. Please note that certain gene sets have special access terms.